Physician profile
Peter Lombard
NPI 1336117217
$3,242.49
in general payments reported to CMS, 2019-2025
8 companies · $1,050 in 2025
The $1,050 reported for 2025 was more than what 78% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.23 · 2020: $253 · 2021: $243 · 2022: $296 · 2023: $454 · 2024: $871 · 2025: $1,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,374.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $859.42 | 2019-2025 | Amo Phaco Needle, Tecnis Iol, Tecnis Iol |
| Sight Sciences, INC. | $806.29 | 2021-2025 | Omni Surgical System |
| Alcon Vision LLC | $740.05 | 2022-2025 | Clareon, Hydrus Microstent, Centurion |
| Regeneron Healthcare Solutions, INC. | $207.27 | 2021-2023 | Eylea |
| Dompe US, INC. | $201.72 | 2023-2025 | Oxervate |
| Amgen INC. | $170.95 | 2024-2025 | Tepezza |
| Allergan, INC. | $137.42 | 2020 | |
| Horizon Therapeutics Plc | $119.37 | 2021-2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lombard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.